HAE - Haemonetics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

HAE is currently covered by 6 analysts with an average price target of $102.07. This is a potential upside of $17.9 (21.27%) from yesterday's end of day stock price of $84.17.

Haemonetics's activity chart (see below) currently has 103 price targets and 103 ratings on display. The stock rating distribution of HAE is 59.38% BUY and 40.63% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 74.65% with an average time for these price targets to be met of 298.45 days.

Highest price target for HAE is $115, Lowest price target is $90, average price target is $102.07.

Most recent stock forecast was given by MICHAEL PETUSKY from BARRINGTON on 13-Feb-2024. First documented stock forecast 18-Nov-2009.

Currently out of the existing stock ratings of HAE, 19 are a BUY (59.38%), 13 are a HOLD (40.63%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

105

$19.68 (23.07%)

105

2 months 4 days ago

19/27 (70.37%)

$33.3 (46.44%)

286

Hold

90

$4.68 (5.49%)

94

4 months 6 days ago

7/10 (70%)

$4.86 (5.71%)

138

Buy

115

$29.68 (34.79%)

105

11 months 5 days ago

6/12 (50%)

$25.55 (28.56%)

237

Buy

115

$29.68 (34.79%)

110

1 years 2 months 9 days ago

12/22 (54.55%)

$32.02 (38.59%)

356

Hold

90

$6.44 (7.71%)

85

1 years 5 months 9 days ago

6/8 (75%)

$8.62 (13.48%)

237

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HAE (Haemonetics) average time for price targets to be met?

On average it took 298.45 days on average for the stock forecasts to be realized with a an average price target met ratio 74.65

Which analyst has the current highest performing score on HAE (Haemonetics) with a proven track record?

MIKE MATSON

Which analyst has the most public recommendations on HAE (Haemonetics)?

Mike Matson works at NEEDHAM and has 37 price targets and 34 ratings on HAE

Which analyst is the currently most bullish on HAE (Haemonetics)?

Raj Denhoy with highest potential upside - $84.82

Which analyst is the currently most reserved on HAE (Haemonetics)?

David Roman with lowest potential downside - -$60.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?